Self-testing of blood glucose: biosensors and beyond.
There is a possible major shake-up on the way in blood glucose monitoring. Sales of disposable electrochemical biosensors now reach approximately US$2.5 billion per annum. However, there are numerous rival technologies on the horizon, which threaten this leading position. These offer the potential to monitor noninvasively or with minimal discomfort. Success in developing any of these has the potential to change the future of self-testing of glucose and many other analytes.